home / stock / kldo / kldo news

KLDO News and Press, Kaleido Biosciences Inc. From 08/01/19

Stock Information
Company Name: Kaleido Biosciences Inc.
Stock Symbol: KLDO
Market: NYSE
Website: /www.kaleido.com
Menu
KLDO KLDO Quote KLDO Short KLDO News KLDO Articles KLDO Message Board
Get KLDO Alerts

News, Short Squeeze, Breakout and More Instantly...
KLDO - Kaleido Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update

LEXINGTON, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced financial results...
KLDO - Kaleido Biosciences to Present at the 39th Annual Canaccord Genuity Growth Conference

LEXINGTON, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced that management w...

KLDO - Kaleido Biosciences Appoints Jerald Korn as General Counsel and Corporate Secretary

LEXINGTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced the appointment o...

KLDO - Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors

LEXINGTON, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced that Theo Melas-K...
KLDO - Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement - Drug Development Summit

Members of leadership team to participate in sessions discussing the role of the microbiome in human disease Summit coincides with World Microbiome Day: June 27, 2019 LEXINGTON, Mass., June 26, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage heal...

KLDO - Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r...

KLDO - Stocks To Watch: Chewy IPO, Lululemon And Tesla On Tap

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
KLDO - Kaleido Biosciences to Present at the Goldman Sachs 40th Annual Global Healthcare Conference

LEXINGTON, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced t...

KLDO - Kaleido Biosciences misses by $0.82

Kaleido Biosciences (NASDAQ: KLDO ): Q1 GAAP EPS of -$1.56  misses by $0.82 . More news on: Kaleido BioSciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

KLDO - Kaleido Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update

LEXINGTON, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health, today announced fi...
Previous 10 Next 10